Reports for SANDOZ IRBESARTAN HCT
Brand name
SANDOZ IRBESARTAN HCT
Company Name
SANDOZ CANADA INCORPORATED
|
Drug Identification Number
02337444 |
Ingredients
HYDROCHLOROTHIAZIDE IRBESARTAN |
Ingredient Strength
25 MG 300 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
SANDOZ IRBESARTAN HCT | 500/Btl | Resolved | 2017-03-14 | 2017-05-08 | 2705 |
SANDOZ IRBESARTAN HCT | 500 | Resolved | 2017-03-15 | 2017-05-08 | 2887 |
SANDOZ IRBESARTAN HCT | 500 | Resolved | 2017-09-07 | 2017-10-25 | 21284 |
SANDOZ IRBESARTAN HCT | 100 | Resolved | 2019-04-01 | 2020-07-20 | 80197 |
SANDOZ IRBESARTAN HCT | 500 | Resolved | 2019-04-01 | 2020-07-20 | 80200 |
SANDOZ IRBESARTAN HCT | 100FCT BO CA | Resolved | 2020-09-21 | 2020-10-27 | 124617 |
SANDOZ IRBESARTAN HCT | 500FCT BO CA | Resolved | 2020-09-21 | 2020-10-27 | 124621 |
SANDOZ IRBESARTAN HCT | 500FCT BO | Resolved | 2021-10-19 | 2021-10-26 | 147570 |
SANDOZ IRBESARTAN HCT | 500FCT | Resolved | 2023-02-14 | 2023-03-28 | 184632 |
SANDOZ IRBESARTAN HCT | 100 FCT BO | Actual shortage | 2023-07-31 | 2023-10-02 | 200534 |
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0